Abstract
Cryptococcosis, a systemic fungal infection, has become a significant, global public health problem. Patients with liver disease have an increased predisposition to infections, such as Cryptococcosis. To report the underlying disease, the variety of etiologic agents involved and the outcomes of the Cryptococcosis in patients living with HBV and/or HCV, we reviewed 34 medical records of patients who were diagnosed with Cryptococcosis by the Mycology Laboratory of Santa Casa Hospital, Porto Alegre, Brazil. Males corresponded to 79 % of the patients, and the average patient age was 46.9 years. The cultures of 26/34 patients were positive: 25 patients were infected with Cryptococcus neoformans and one with C. gattii. A total of 14 deaths (41 %) occurred. As a criterion of our study, all patients had viral hepatitis infection: 27 (80 %) were infected with HCV, five (15 %) were infected with HBV, and two patients were infected with both viruses. Because HBV and/or HCV are transmitted among drug users through infected blood, and the end-stage cirrhotic liver must be transplanted, these two population types were well represented in this study and were analyzed in detail. Cryptococcosis patients living with HCV and/or HBV appear to have the same symptoms, mean age and gender distribution as the general Cryptococcosis population. Once Cryptococcosis affects the brain, a high mortality rate ensues; therefore, physicians must be aware of the possible occurrence of this disease in patients living with HCV and HBV.
Similar content being viewed by others
References
Jackson A, van der Horst C. New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis. Curr HIV/AIDS Rep. 2012;9:267–77.
Negroni R. Cryptococcosis. Clin Dermatol. 2012;30:599–609.
Byrnes EJ, Li W, Lewit Y, Ma H, Voelz K, Ren P, et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog. 2010;22:e1000850.
Datta K, Bartlett KH, Baer R, Byrnes E, Galanis E, Heitman J, et al. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis. 2009;15:1185–91.
Patel M, Beckerman KP, Reznik S, Madan RP, Goldman DL. Transplacental transmission of Cryptococcus neoformans to an HIV-exposed premature neonate. J Perinatol. 2012;32:235–7.
Baddley JW, Schain DC, Gupte AA, Lodhi SA, Kayler LK, Frade JP, et al. Transmission of Cryptococcus neoformans by organ transplantation. Clin Infect Dis. 2011;52:94–8.
Saif MW, Raj M. Cryptococcal peritonitis complicating hepatic failure: case report and review of the literature. J Appl Res. 2006;6:43–50.
Singh N, Husain S, de Vera M, Gayowski T, Cacciarelli TV. Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant candidates. Medicine. 2004;83:188–92.
El-Serag HB, Anand B, Richardson P, Rabeneck L. Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol. 2003;98:167–74.
Balogun TM, Emmanuel S, Ojerinde EF. HIV, Hepatitis B and C viruses’ coinfection among patients in a Nigerian tertiary hospital. Pan Afr Med J. 2012;12:100.
WHO. Hepatitis B fact sheet N°204. 2012. http://www.who.int/mediacentre/factsheets/fs204/en/index.html. Accessed Apr 8 2013.
WHO. Hepatitis C fact sheet N°164. 2012. http://www.who.int/mediacentre/factsheets/fs164/en/index.html. Accessed Apr 8 2013.
Leal AL, Faganello J, Fuentefria AM, Boldo JT, Bassanesi MC, Vainstein MH. Epidemiological profile of cryptococcal meningitis patients in Rio Grande do Sul. Braz Mycopathol. 2008;166:71–5.
Pyrgos V, Seitz AE, Steiner CA, Prevots DR, Williamson PR. Epidemiology of cryptococcal meningitis in the US: 1997–2009. PLoS One. 2013;8:e56269.
Cleophas V, George V, Mathew M, Samal SC, Chandy GM. Spontaneous fungal peritonitis in patients with hepatitis B virus-related liver disease. J Clin Gastroenterol. 2000;31:77–9.
Miranda ÉJ, Gonçalves LG, França FO. Cryptococcal meningitis in HIV-negative patient with liver cirrhosis due to hepatitis C. Braz J Infect Dis. 2011;15:399–400.
Miura T, Kawakami Y, Otsuka M, Hachiya M, Yamanoi T, Ohashi K, et al. Cutaneous cryptococcosis in a patient with cirrhosis and hepatitis C virus infection. Acta Derm Venereol. 2010;90:106–7.
Paliwal VK, Gupta PK, Rai P, Verma R. Cryptococcal meningitis in a patient with hepatitis C virus related decompensated cirrhosis: coincidental or immunologically related? Trop Gastroenterol. 2012;33:146–8.
Min KH, Kwon-Chung KJ. The biochemical basis for the distinction between the two Cryptococcus neoformans varieties with CGB medium. Zentrabl Bakteriol Mikrobiol Hyg A. 1986;261:471–80.
Lindenberg AS, Chang, Paniago AM, Lazéra Mdos S, Moncada PM, Bonfim GF, et al. Clinical and epidemiological features of 123 cases of cryptococcosis in Mato Grosso do Sul, Brazil. Rev Inst Med Trop São Paulo. 2008;50:75–8.
Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis. 2000;31:499–508.
Dromer F, Mathoulin-Pe`lissier S, Fontanet A, Ronin O, Dupont B, Lortholary O. Epidemiology of HIV-associated cryptococcosis in France (1985–2001): comparison of the pre- and post-HAART eras. AIDS. 2004;18:555–62.
Tay ST, Rohani MY, Hoo TS, Hamimah H. Epidemiology of cryptococcosis in Malaysia. Mycoses. 2010;53:509–14.
Bratton EW, El Husseini N, Chastain CA, Lee ML, Poole C, Stürmer T, et al. Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis. Antimicrob Agents Chemother. 2013;57:2485–95.
Severo CB, Xavier MO, Gazzoni AF, Severo LC. Cryptococcosis in children. Paediatr Respir Rev. 2009;10:166–71.
Mühlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health. 2009;22:34.
Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41–52.
Parikh N, Nonnemacher MR, Pirrone V, Block T, Mehta A, Wigdahl B. Substance abuse, HIV-1 and hepatitis. Curr HIV Res. 2012;10:557–71.
Quan VM, Go VF, le Nam V, Bergenstrom A, Thuoc NP, Zenilman J, et al. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study. AIDS Care. 2009;21:7–16.
Nelson P, Mathers B, Cowie B, Hagan H, Jarlais DD, Horyniak D, et al. The epidemiology of viral hepatitis among people who inject drugs: results of global systematic reviews. Lancet. 2011;378:571–83.
Pappalardo MCSM, Melhem MSC. Cryptococcosis: a review of the Brazilian experience for the disease. Rev Inst Med Trop São Paulo. 2003;45:299–305.
Acknowledgments
We wish to thank Sídia Maria Callegari-Jacques for assistance with the statistical analysis. This work was supported by the Coordenação de Aperfeiçoamento de Pessoal do Ensino Superior (CAPES).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spies, F.S., de Oliveira, M.B., Krug, M.S. et al. Cryptococcosis in Patients Living with Hepatitis C and B Viruses. Mycopathologia 179, 307–312 (2015). https://doi.org/10.1007/s11046-014-9843-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-014-9843-4